Los Angeles, CA – Legendary Trauma Therapist, Dr. Cheri McDonald releases her third book “Healing the Healer Within: 8 Secrets to Unleashing Your Potential”
In this book you will learn how to: · Conquer imposter syndrome and start believing in yourself · Express confidence in being a healer · Start doing the work you are called to right now. · Keep going even when doubts arise · Love the Healer you’ve become
Dr. Cheri McDonald is a 35-year veteran that runs one of the hottest psychotherapy practices in the country. She is a bestselling author of 2 books with her 3rd on its way. Dr. Cheri is the founder of the #breakfree movement and she believes that we are bombarded with hate and negativity every day and this is contrary to our human nature. It impacts our ability to trust and become personally vulnerable. This can leads to a cycle of loneliness and isolation which can be difficult to break. According to Dr. Cheri, therapy is a great practice where individuals can gain tools and relief, but oftentimes the work a patient does in the therapy room does not get translated to the real world. Dr. Cheri is dedicated to helping individuals break free of their trauma and rise up to be their best self. She has been featured on NBC, Good Morning La La Land, Fox, The Today Show, KUSI San Diego, Shape Magazine, MSN and numerous others. Her articles have been viewed by over 10 million readers.
CAE receives Health Canada certification for its life-saving CAE Air1™ ventilator
MONTREAL, June 17, 2020 /CNW Telbec/ - (NYSE: CAE) (TSX: CAE) – CAE announced today that its CAE Air1™ ventilator has been certified by Health Canada. This made-in-Canada ventilator is destined for hospitals across the country where it will be used in the fight against COVID-19. Certification comes two months after CAE signed a contract with the Government of Canada to manufacture and supply 10,000 ventilators.
"Since the beginning of the pandemic, CAE was the first to receive certification from Health Canada for an entirely new ventilator. It was created and manufactured in Canada, and we are proud that it will help save lives in the fight against COVID-19," said Marc Parent, CAE's President and CEO. "The agility shown by CAE in designing and succeeding to have the CAE Air1 ventilator certified in a fraction of the usual time is a testament to the strength of CAE's innovation, engineering talent, and advanced manufacturing capabilities. I am proud of our team for rising to this humanitarian challenge and strengthening Canada's self-sufficiency in the medical field during these unprecedented times."
CAE will now start shipping hundreds of CAE Air1 ventilators to the Government of Canada every week. The CAE Air1 ventilator can deliver pressure control, volume control and pressure support ventilation using room air or pressured oxygen. It uses an intuitive, simple touchscreen interface and is bundled with on-demand ventilator training, adaptive e-learning modules related to COVID-19 patient management, and 24/7 customer support. It will support Intensive Care Units patients treated for COVID-19.
"CAE, one of Canada's leading aerospace firms, stepped up early on with their commitment to produce a made-in-Canada ventilator design that will help save the lives of COVID-19 patients battling the disease. Today's announcement is a testament to CAE's agility and innovative capability. I am glad that we were able to support CAE in accelerating the design and manufacturing of CAE Air1 ventilator that is now ready to be used by our frontline healthcare workers," said the Honourable Navdeep Bains, Canada's Minister of Innovation, Science and Industry.
Quick facts:
CAE Air1 ventilator is designed and manufactured in Montreal, Canada
Over 500 CAE employees from 45 departments have worked on the project so far
The CAE Air1 ventilator has over 500 parts
More than 130 Canadian suppliers were chosen. To access the list of CAE Air1 suppliers / distributors/ collaborators in Canada: click here
CAE is a global leader in training for the civil aviation, defence and security, and healthcare markets. Backed by a record of more than 70 years of industry firsts, we continue to help define global training standards with our innovative virtual-to-live training solutions to make flying safer, maintain defense force readiness and enhance patient safety. We have the broadest global presence in the industry, with over 10,500 employees, 160 sites and training locations in over 35 countries. Each year, we train more than 220,000 civil and defence crewmembers, including more than 135,000 pilots, and thousands of healthcare professionals worldwide. www.cae.com
Follow us on Twitter: CAE_Inc
SOURCE CAE INC.
Endometriosis: an invisible disease affecting half a million Canadians
500,000+ Canadian girls and women are affected by endometriosis.1
27.9 years old is the average diagnosis age in Canada. 1
In Canada, individuals with endometriosis often experience a diagnosis delay of more than five years. 1
MONTREAL, June 17, 2020 /CNW/ - AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company, sponsored a first of its kind cross-sectional, online survey of 30,000 women in Canada aged 18 to 49. Earlier this year, the results were published in the Journal of Obstetrics and Gynaecology Canada (JOGC) in a paper entitled "Prevalence, Symptomatic Burden, And Diagnosis Of Endometriosis In Canada: Cross-Sectional Survey Of 30 000 Women."1
Findings showed that Canadians with endometriosis often experience a diagnosis delay of more than five years. This half decade delay in disease recognition indicates an important unmet need for more timely diagnosis of endometriosis across Canada.1
"Often misdiagnosed and mismanaged; endometriosis can have a significant negative impact on a person's physical and mental health and dramatically hinder their overall quality of life. Women need to know that painful periods are not normal. There are treatment options available, as long as endometriosis is identified quickly. Unfortunately, that is not always the case," says Dr. Sukhbir Singh, MD, Professor, Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, who is a primary investigator in the study.
In Canada, it's estimated that seven per cent of women will develop endometriosis.1 Endometriosis is a chronic inflammatory disease that predominantly affects women of reproductive age.2 Endometriosis occurs when endometrial tissue grows outside the uterus. Women with endometriosis experience various symptoms including: non-menstrual pelvic pain, pain during intercourse (dyspareunia), heavy menstrual bleeding, pelvic pain, and cramping during menstruation.3 Infertility can also be common with endometriosis.3
"The road for an endometriosis patient is long, with various treatments and no cure. I deal with the physical aspect as well as the emotional and mental pull of it all," said Alexandra Camara, a Canadian living with endometriosis. "I became symptomatic at an early age. My symptoms increased and became more relevant when I was 14, and at 19, I was formally diagnosed. Receiving a proper diagnosis, then later excision surgery, was monumental to symptom management. To help raise awareness, I'm sharing my story to empower women not to suffer in silence."
According to a survey, seven out of ten women experience unresolved – on-going - endometriosis pain.4 Endometriosis is a life-long journey. Often, patients who are diagnosed and on treatment, or have had surgery, still deal with unmanaged pain. It is important for patients to have continuous support, knowledge and access to clinically proven treatments. If still in pain, be your own advocate, seek out options and speak to a health care expert about all treatment options.
Globally, an estimated 176 million women live with endometriosis.5 "Although there is currently no cure for endometriosis, we are committed to researching and supporting Canadians living with endometriosis in an effort to provide resources and hope for this disease," said Denis Hello, Vice President and General Manager, AbbVie Canada. "AbbVie has conducted some of the largest clinical trials in endometriosis in the world. We will continue to research the disease's most common symptoms to support disease management needs."
Resources such as the Endometriosis Network Canada and online chats via #EndoEmpowered can provide important information and foster a sense of community for endometriosis patients in Canada.
About AbbVie AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
4 De Graaff AA, D'Hooghe TM, Dunselman GAJ, Dirksen CD, Hummelshoj L, WERF EndoCost Consortium, Simoens S. The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod. 2013;28(10):2677-2685. Accessed May 2020.
5 David Adamson, G., Kennedy, S., & Hummelshoj, L. (2010). Creating solutions in endometriosis: Global collaboration through the world endometriosis research foundation. Journal of Endometriosis, 2(1), 3-6. Accessed May 2020.
SOURCE AbbVie Canada
Report: Youth Vaping Rate Increased with Anti-Vaping Campaigns
WASHINGTON, June 17– Today the Competitive Enterprise Institute released a report on the connection between underage e-cigarette use and anti-vaping advocacy.
“Anti-vaping public messaging campaigns by government, advocacy groups, and the media backfired. Teen vaping did not escalate despite the increased anti-vaping messaging but because of it,” said Michelle Minton, CEI senior fellow and author of the report. “Looking at the timeline, underage vaping rates went up along with anti-vaping campaigns that unintentionally portrayed vaping as cool and rebellious.”
The rate of high school students reporting past-month use of e-cigarettes plummeted from 2015 to 2016 but then surged again by 2018. (See chart below.)
The report details a number of multi-million-dollar ad campaigns that were likely culprits. For example, a 2016 ad by the FDA called “Don’t Get Hacked” that entertained with ominous music mimicking the soundtrack of a slasher film playing with images of teenagers vaping. In one instance, a young woman walks into a dark alley to use her e-cigarette. Risky, cinematic, cool!
All the counter-productive ad campaigns relied on wrong-headed tactics:
Making explicit demands on behavior;
Raising awareness about products or behaviors that did not exist before;
Making a product/behavior seem more attractive; or
Portraying the behavior as common or “normal.”
Minton urges other ways to curb underage use of e-cigarettes, such as aiming communications at adults and giving the public—including adolescents—accurate, non-sensationalized information about the relative risks of noncombustible versus combustible forms of tobacco and nicotine consumption. The report also emphasizes some inescapable facts: Cigarette smoking kills approximately half of smokers who sustain the habit over their lifetime, whereas e-cigarettes are an estimated 95 percent less harmful.
“Health advocates should encourage smokers who have trouble quitting to at least switch to a product that delivers nicotine without combustion,” Minton explained.
Virtual Brain Tumour Walk unites all Canadians in the fight against brain tumours June 27
Register now and help Brain Tumour Foundation of Canada #EndBrainTumours
LONDON, ON, June 17, 2020 /CNW/ - On Saturday, June 27, Brain Tumour Foundation of Canada is ready to make history with its first-ever national 2020 Virtual Brain Tumour Walk.
Normally held on multiple days across several cities in Canada, this year's event has merged 22 different walks into a single virtual event. The move was made in order to keep the brain tumour community and its supporters safe in light of COVID-19.
It's a necessary move from a fundraising standpoint, as charities across Canada are feeling the pinch this year due to in-person events being cancelled. However, Brain Tumour Foundation of Canada has received some spectacular support from two well-known Canadian celebrities.
Joining Brain Tumour Foundation of Canada this year is two-time Olympic gold medal curler, Kaitlyn Lawes of Winnipeg. Lawes' father, Keith, passed away from a brain tumour in 2007. It has taken some time, but Kaitlyn says she feels ready to share a more vulnerable side of herself, by sharing her story with the country and Brain Tumour Foundation of Canada.
My Story – By Kaitlyn Lawes is currently featured on Brain Tumour Foundation of Canada's web site, and is a beautifully written account of her father's battle with a brain tumour, even as she rose to the peak of her sport.
Hosting the 2020 Virtual Brain Tumour Walk is Canadian broadcasting legend, Alan Cross, who will take participants through the half-hour ceremony on Facebook Live beginning at 12pm EDT. Cross, the voice behind the Ongoing History of New Music podcast, will be checking in with survivors, caregivers and volunteers from all across Canada leading up to the big countdown.
Meanwhile, what could be more fitting for a walk hosted over social media than a hashtag sponsor?
Every time the hashtag #VirtualBrainTumourWalk is used on June 27, Al's Flower Pouch, by A.M.A. Horticulture Inc will be donating 27 cents to Brain Tumour Foundation of Canada.
For nearly 20 years A.M.A. Horticulture Inc has supported Tumour Foundation of Canada through the sale of Al's Flower Pouch hanging planters. More than one million pouches have been sold, each featuring Brain Tumour Foundation of Canada's logo and contact information.
The 2020 Virtual Brain Tumour Walk is open to all Canadians to take part in. How you do is up to you – walk, dance, jog, run – but no matter what, it all helps raise awareness of the 27 people who are diagnosed with a brain tumour each day in Canada, as well as raise funds to help the search for the cause of and cure for brain tumours.
Register yourself or a team today at www.braintumourwalk.ca, and take your first steps to #EndBrainTumours.
Click here to read the personal stories of Brain Tumour Foundation of Canada's Virtual Brain Tumour Walk ambassadors from all across Canada.
Facts about brain tumours Each day in Canada, 27 people will hear the words, "You have a brain tumour." There are an estimated 55,000 Canadians currently living with a brain tumour. Signs and symptoms can include headaches, dizziness, blurred vision and behavioural changes, in addition to morning nausea, hearing impairment and weakness or paralysis. There are more than 120 different types of brain tumours, making effective treatment very complicated.
About Brain Tumour Foundation of Canada: Brain Tumour Foundation of Canada is the only national charity offering information and support to patients affected by any kind of brain tumour – be it cancerous, non-malignant or metastases. The organization funds ground-breaking research across North America and, since 1982, has dedicated over $7.2 million to finding a cure and improving treatment for brain tumour survivors. Brain Tumour Foundation of Canada is funded solely through generous contributions from individuals, corporations, organizations, employee groups and special events. Learn more at Brain Tumour Foundation of Canada's website: www.BrainTumour.ca.
SOURCE Brain Tumour Foundation of Canada
50+ And Healthy Examines The Importance Of Mental Health As We Age
Chicago, IL, June 17, 2020 — The worldwide stay-at-home orders have turned weekend warriors into daily dog walkers, joggers and cyclists — all hoping to stay fit and avoid the “quarantine 15.” But there’s more to being healthy than having a fit physique. Mental health is equally important, but often gets buried beneath the stigma surrounding it.
“Many of you recognize that mental illness is often a taboo subject … due to seeming complexity, mystery and stigma,” explains Murali Rao, MD. “Unfortunately, the high discrimination of the subject leads to a statistic of nearly two-thirds of the world population refusing to seek help for mental health related issues.” Adding: “Though this primer is directed towards learning to help elders, the material can readily apply to any age group.”
Rao, an expert on clinical geriatrics and geriatric psychiatry, addresses the concepts of mental health and mental illnesses in the overarching context of healthy aging in 50+ and Healthy: What You Need to Know About Mental Health and Healthy Aging — for You and Your Loved Ones. This exceptionally strong, evidence-based guide emphasizes the importance of nurturing our mental health as we grow older.
Using easy-to-understand language, he explores common health-related conditions, how to recognize symptoms, practical approaches to treatments and his GAME PLANTMmethod for helping yourself and your loved ones, of any age, during times of distress or mental health crises.
For readers of any educational and professional background, 50+ and Healthy offers easily presented information and relatable case studies.
With this book, you can learn from a world authority about:
1. Healthy aging and mental health
2. Common mental illnesses, why people get them, how to identify them and how to manage them
3. Practical approaches for first aid and later interventions
4. Self-care for mental health and successful aging
If you are interested in healthy aging and how to help yourself, your family members and your friends with mental health, this book is for you. All proceeds from book sales go to a nonprofit organization engaged in mental health awareness education in the United States and India (www.nndcifoundation.org), founded by Dr. Murali Rao.
Author Murali Rao, MD, is a professor and chairman of the Department of Psychiatry and Behavioral Neurosciences at Loyola University Medical Center in Chicago. He specializes in liaison and emergency psychiatry. Additionally, he serves as a member of multiple professional bodies including the American College of Psychiatrists, the Academy of Psychosomatic Medicine, CINP, the Indian Psychiatric Society and serves on the Scientific Advisory Board of the Depression and Bipolar Support Alliance (DBSA).
Dr. Rao has received multiple awards and fellowships, including Distinguished Life Fellow by the APA, Outstanding Academician Award by the Indo-American Psychiatric Association and the Master Teacher Award by the Stritch School of Medicine. Dr. Rao has also had more than 80 journal publications, books and book-chapters. He has recently published trainee and trainer manuals on Adult Mental Health, Substance Abuse and Workplace Mental Health.
For more information, please visit www.nndcifoundation.org, or follow the author on Twitter at @MuraliRaoMD.
50 + and Healthy: What You Need to Know About Mental Health and Healthy Aging — for You and Your Loved Ones
Sirnaomics and Precision NanoSystems Have Formed a Partnership
Developing and Manufacturing Novel RNAi drug Candidates Using Precision NanoSystems' NxGen™ Platform
GAITHERSBURG, MD and VANCOUVER, BC, June 17, 2020 /CNW/ - Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of Sirnaomics polypeptide nanoparticle-based RNAi therapeutic product. This strategic joint effort includes the execution of a NanoAssemblr® platform license and supply agreement, plus successful production of multiple batches of Sirnaomics drug product candidates, STP705 and STP707, for ongoing IND enabling safety and toxicity studies, as well as several clinical studies.
Sirnaomics is a clinical stage biopharmaceutical company specialized in RNAi-based therapeutics for addressing the unmet needs in treatment of cancers and fibrosis diseases. The company has developed proprietary polypeptide nanoparticle carriers for efficient siRNA delivery, to advance an enriched drug product pipeline. Sirnaomics' lead product candidate, STP705, is an siRNA (small interfering RNA) therapeutic which takes advantage of a dual-targeted inhibitory property together with a polypeptide nanoparticle (PNP)-enhanced delivery to directly knock down both TGF-β1 and COX-2 gene expression. The product candidate has received multiple IND approvals from both the US FDA and Chinese NMPA, including treatments of Cholangiocarcinoma, Non-Melanoma skin cancer and Hypertrophic Scar. STP705 has also received Orphan Drug Designation for treatment of Cholangiocarcinoma, Primary Sclerosing Cholangitis and Hepatocellular Carcinoma. A recent interim analysis report of a phase IIa clinical study on STP705 for treatment of Squamous Cell Carcinoma in situ indicated the topline therapeutic results with complete histological clearance tumor cell on treated sites. Using the same dual targets design, Sirnaomics has further developed STP707, a systemic formulation with broader application potential.
Sirnaomics' founder, president and CEO, Dr. Patrick Lu said, "As the leader in RNAi therapeutics specialized in polypeptide nanoparticle formulation, we are so excited to see the further advancement of our process development and large scale product manufacturing, using PNI's NxGen™ microfluidic technology. In working with PNI's team and the NanoAssemblr platform, we were able to establish a robust manufacturing process from a nominated drug candidate to GMP manufacturing in just a few months, greatly accelerating our drug development process". Sirnaomics is currently using these batches produced with NxGen™ for non-human primate safety toxicity studies and clinical studies."
PNI is a global leader in technology solutions to enable the development and manufacture of new nanomedicines in the areas of vaccines, cell therapies and gene therapies for the treatment of oncology, infectious diseases, and rare diseases. With the NanoAssemblr suite of products, PNI provides solutions across the drug development process for clients to develop and seamlessly scale their drug programs. Dr. James Taylor, co-founder and CEO of PNI said, "We are pleased to support Sirnaomics, an innovative RNAi therapeutics company, with our NanoAssemblr platform and Clinical Solutions Team that helped take their drug program to a successful GMP batch manufacture. We believe the NanoAssemblr microfluidic technology enables exquisite control over the particle size, charge and encapsulation efficiency which was important for the performance of Sirnaomics' drug product candidates." PNI's NanoAssemblr platform, with over 400 systems placed worldwide, is designed to enable drug developers to rapidly progress from R&D to industrial-scale nanomedicine manufacture.
About Sirnaomics Sirnaomics, Inc., a leading privately held biopharmaceutical company for discovery and development of RNAi therapeutics, is a Delaware corporation headquartered in Gaithersburg, Maryland, USA, with subsidiaries in Suzhou and Guangzhou, China. The Company's mission is to develop novel therapeutics to alleviate human suffering and advance patient care in areas of high unmet medical need. The guiding principles of the company are: Innovation, Global Vision with a Patient Centered focus. Members of the senior management team have a great deal of combined experience in the biopharmaceutical industry, financial, clinical and business management in both the USA and China. The company is supported by funding from institutional investors, corporate partnerships and government grants. Sirnaomics has developed a strong portfolio of intellectual property with an enriched product pipeline. The therapeutic areas of focus include oncology and anti-fibrotic therapeutics. Learn more at www.sirnaomics.com.
About Precision NanoSystems Inc. Precision NanoSystems Inc. (PNI) proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology. For more information visit http://www.precisionnanosystems.com.
Your immune system is significantly impacted by your level of stress, attitude, mood and emotional state. When you’re optimistic and happy, your immune system functions properly. But constant exposure to stress hormones does not do a body good.
Everyone has stress; it's an inevitable part of life. However, if you’re seriously stressed out for a long time, you’re going to be more prone to illness. During this time of the COVID-19 pandemic, we’re all dealing with more stress than usual. This makes knowing how to handle stress more important than ever.
A few effective ways of managing your stress are:
Meditating
Slowing down
Counseling can also help greatly
Here are some other tips on how you can de-stress:
Breathe
Besides helping you calm down, deep belly breaths can also help you fight off bugs, germs and other invaders. When you breathe deeply, you activate a muscle called the diaphragm, which is located above the gut and internal organs and below the lungs. By activating your diaphragm, you’re giving a massage to your internal glands and organs. This movement helps move lymph, which contains white blood cells, through your body.
Get enough sleep
You may have noticed that you tend to catch a cold or other infections more often when you're not getting enough sleep. Studies show that well-rested people who got the flu vaccine developed stronger protection against the sickness.
Not sleeping enough can lead to higher levels of stress hormones. It can also lead to more inflammation in the body. Although researchers aren’t exactly certain as to how sleep helps the immune system, it’s clear that adequate sleep—usually seven to nine hours on average for an adult—is essential for your good health.
Move your body
Bodily movement improves your heart health, releases feel-good chemicals that fight stress and helps you release anxiety. Ideally, practice 30 minutes of aerobics and 5 to 10 minutes of stretching daily, while also including deep breathing and relaxation.
While working out, your body’s levels of white blood cells and other illness-fighting agents increase. These immune system fighters look for and attack viruses. The more active you are, the more efficient your immune system tends to be.
The key is to exercise regularly—but not too much. Overexertion without timely breaks can be counterproductive, actually increasing your stress and suppressing your immune function. Consider exercising in the great outdoors, or be very aware of your gym or studio’s social distancing and sanitization efforts.
Laugh
Several studies have shown that sustained humor and laughter can boost your immune system by increasing the number of antibodies and increasing the activity of immune system cells, such as white blood cells and t-cells. Laughing lowers your levels of stress hormones (adrenaline and cortisol), which weaken immunity. It also increases your levels of hormones that improve mood and immunity (human growth hormone and beta-endorphins).
Strengthen your social bonds
Social connection and support are vital to your general well-being and also help supply your body with feel-good hormones like oxytocin. Even if we’re still social distancing, you can talk with friends and family on the phone or by video chat.
Do you need help with stress management? Learn more about the most effective ways to stay healthy at Durisan.com.
Jennifer Dodd, national strategies pr
Office: (813) 865-3093 I Mobile: (813) 767-7895
3030 North Rocky Point Drive West, Suite 150, Tampa, FL 33607
Confidential: This electronic message and all contents contain information from National Strategies Public Relations which may be privileged, confidential or otherwise protected from disclosure. The information is intended to be for the addressee only. If you are not the addressee, any disclosure, copy, distribution or use of the contents of this message is prohibited. If you have received this electronic message in error, please notify the sender and destroy the original message and all copies.
In-Home Seniors Healthcare Is The Safer Alternative Especially During COVID-19 Pandemic
Statistics show dramatically lower COVID-19 cases for persons receiving healthcare in their own homes
TORONTO, June 17, 2020 /CNW/ - COVID-19 has no doubt taken a toll on society and the way Canadians live but no other demographic has been harder hit than those over 75 years, our seniors.
According to the latest Government of Canada COVID-19 statistics, within a few weeks of Canada's first imported case of COVID-19, outbreaks were identified in long-term care and seniors' homes. As of June 10, 2020, outbreaks related to these settings are responsible for 18 per cent of cases and 82 per cent of deaths in Canada. The high mortality associated with COVID-19 in long-term care settings reflects the vulnerability of this senior population.i
Bayshore HealthCare visits and cares for more than 35,000 seniors every single day in their own homes and over 245,000 home care visits every single week across Canada. Yet the amount of COVID-19 cases is dramatically lower.
Bayshore's data shows that only 0.36 per cent of their home care clients acquired COVID-19, resulting in no deaths while under their care and only 0.1 per cent of their home care employees (or eight staff) have acquired COVID-19. In fact, none of their patients or clients have contracted COVID-19 from their staff. (Figure 1)
"Data clearly illustrates that seniors who live at home and receive in-home care have lower COVID-19 rates than institutionalized care," says Maureen Charlebois, Chief Nursing & Clinical Officer at Bayshore HealthCare. "Our seniors deserve the dignity of staying in their own homes with excellent reliable care. Tragically, COVID-19 has proven that home care isn't just a better experience, with this disease, it has vastly better health outcomes."
According to Charlebois, "home care provides evidenced based person-centred care leading to better health outcomes at the individual level and at a system level by alleviating the pressure on other parts of the healthcare system - hospitals and long-term care homes. Our in-home healthcare teams are the quiet unsung heroes, especially during this COVID-19 pandemic."
"Not only do our in-home healthcare teams care for seniors with a myriad of healthcare needs including dementia, Alzheimer's, cancer care, and chronic disease management, they've also gone above and beyond their call of duty when they stepped up to help at the onset of the crisis in long-term care homes when there was no one else available to help."
Bayshore HealthCare began preparing the organization for the possibility of a pandemic even before COVID-19 hit. They started with enhanced safety precautions, education and implemented a strict infection prevention and control program designed to prevent the spread of infection.
With the advancement of digital technology and telemedicine, Bayshore's new digital platforms enabled nurses and other members of the healthcare team to securely and conveniently connect with seniors and their families to provide advice, support and guidance to help them better manage a medical condition or simply get answers to questions.
Canada's National 2017 Census revealed that there are now 5.9 million seniors, compared to 5.8 million Canadians aged 14 years and under.ii This increase means that caring for seniors and the aging population is now than ever more important.
"It is more important now than it has ever been to have enabling policies at the Federal and Provincial level to allow seniors to stay in their own homes and receive the care they need and deserve," says Charlebois.
About Bayshore HealthCare: Bayshore HealthCare is one of the country's leading providers of home and community health care services and is a Canadian-owned company. With over 100 locations across the country, including 65 home care offices, 13 pharmacies and 81 community care clinics, Bayshore has more than 13,000 staff members and provides care to over 350,000 clients. Its services are purchased by government care programs, insurance companies, workers' compensation boards, health care organizations, the corporate sector and the public. The Bayshore brand extends across four business divisions: Bayshore Home Health (medical and non-medical home care and staffing services), Bayshore Home Care Solutions (home care services for government care programs), Bayshore Specialty Rx (specialty pharmacy, infusion and pharmaceutical patient support services), and Bayshore Therapy & Rehab (physiotherapy and rehabilitation services). The company's goal is to enhance the quality of life, well-being, dignity and independence of Canadians of all ages. Bayshore HealthCare has been a recipient of Canada's Best Managed Companies award since 2006.
In-Home Seniors Healthcare Is The Safer Alternative Especially During COVID-19 Pandemic
Statistics show dramatically lower COVID-19 cases for persons receiving healthcare in their own homes
TORONTO, June 17, 2020 /CNW/ - COVID-19 has no doubt taken a toll on society and the way Canadians live but no other demographic has been harder hit than those over 75 years, our seniors.
According to the latest Government of Canada COVID-19 statistics, within a few weeks of Canada's first imported case of COVID-19, outbreaks were identified in long-term care and seniors' homes. As of June 10, 2020, outbreaks related to these settings are responsible for 18 per cent of cases and 82 per cent of deaths in Canada. The high mortality associated with COVID-19 in long-term care settings reflects the vulnerability of this senior population.i
Bayshore HealthCare visits and cares for more than 35,000 seniors every single day in their own homes and over 245,000 home care visits every single week across Canada. Yet the amount of COVID-19 cases is dramatically lower.
Bayshore's data shows that only 0.36 per cent of their home care clients acquired COVID-19, resulting in no deaths while under their care and only 0.1 per cent of their home care employees (or eight staff) have acquired COVID-19. In fact, none of their patients or clients have contracted COVID-19 from their staff. (Figure 1)
"Data clearly illustrates that seniors who live at home and receive in-home care have lower COVID-19 rates than institutionalized care," says Maureen Charlebois, Chief Nursing & Clinical Officer at Bayshore HealthCare. "Our seniors deserve the dignity of staying in their own homes with excellent reliable care. Tragically, COVID-19 has proven that home care isn't just a better experience, with this disease, it has vastly better health outcomes."
According to Charlebois, "home care provides evidenced based person-centred care leading to better health outcomes at the individual level and at a system level by alleviating the pressure on other parts of the healthcare system - hospitals and long-term care homes. Our in-home healthcare teams are the quiet unsung heroes, especially during this COVID-19 pandemic."
"Not only do our in-home healthcare teams care for seniors with a myriad of healthcare needs including dementia, Alzheimer's, cancer care, and chronic disease management, they've also gone above and beyond their call of duty when they stepped up to help at the onset of the crisis in long-term care homes when there was no one else available to help."
Bayshore HealthCare began preparing the organization for the possibility of a pandemic even before COVID-19 hit. They started with enhanced safety precautions, education and implemented a strict infection prevention and control program designed to prevent the spread of infection.
With the advancement of digital technology and telemedicine, Bayshore's new digital platforms enabled nurses and other members of the healthcare team to securely and conveniently connect with seniors and their families to provide advice, support and guidance to help them better manage a medical condition or simply get answers to questions.
Canada's National 2017 Census revealed that there are now 5.9 million seniors, compared to 5.8 million Canadians aged 14 years and under.ii This increase means that caring for seniors and the aging population is now than ever more important.
"It is more important now than it has ever been to have enabling policies at the Federal and Provincial level to allow seniors to stay in their own homes and receive the care they need and deserve," says Charlebois.
About Bayshore HealthCare: Bayshore HealthCare is one of the country's leading providers of home and community health care services and is a Canadian-owned company. With over 100 locations across the country, including 65 home care offices, 13 pharmacies and 81 community care clinics, Bayshore has more than 13,000 staff members and provides care to over 350,000 clients. Its services are purchased by government care programs, insurance companies, workers' compensation boards, health care organizations, the corporate sector and the public. The Bayshore brand extends across four business divisions: Bayshore Home Health (medical and non-medical home care and staffing services), Bayshore Home Care Solutions (home care services for government care programs), Bayshore Specialty Rx (specialty pharmacy, infusion and pharmaceutical patient support services), and Bayshore Therapy & Rehab (physiotherapy and rehabilitation services). The company's goal is to enhance the quality of life, well-being, dignity and independence of Canadians of all ages. Bayshore HealthCare has been a recipient of Canada's Best Managed Companies award since 2006.
